TORONTO, Sept. 07, 2017 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pleased to announce it has entered into a consulting services agreement with Stoic Advisory Inc. (“Stoic”), to support the Company with ongoing business development initiatives and capital markets strategy.



“Stoic adds considerable strength to WeedMD at a pivotal time as we execute on a number of exciting pipeline initiatives including, but not limited to, production expansion, seniors and long-term-care partnerships, and opportunities aimed at rounding out our brand and product portfolio,” said Bruce Dawson-Scully, CEO of WeedMD. “With key licensing milestones achieved over the past few months (see press releases), we are now focused on building the business. The team at Stoic brings industry-specific expertise and a deep network of relationships that WeedMD looks forward to leveraging as we enter a new phase of growth.”

Stoic was founded in 2016 by cannabis industry expert Aaron Salz, and later joined by former industry analyst Mason Brown. It has quickly become a highly reputable consulting firm focused on providing strategic corporate finance advisory services and transactional support to companies within the global cannabis industry.

“Since my entry into this industry, I’ve encountered few companies as entrepreneurial and driven as WeedMD,” said Aaron Salz, CEO of Stoic. “It goes without saying that this industry is gearing up for an explosive phase of growth, and we look forward to helping WeedMD execute on several exciting initiatives in the lead up to Canada’s expected adult use market.”

For more information on WeedMD, access our investor presentation on our website here.

About WeedMD Inc.

WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). WeedMD operates a 26,000-square foot, scalable production facility in Aylmer, Ontario with four acres of property for future expansion. WeedMD is focused on providing consistent, quality medicine to the long-term care and assisted living markets in Canada through its comprehensive platform developed exclusively for that industry. WeedMD is dedicated to educating healthcare practitioners and furthering public understanding of the role medical cannabis can play as a viable alternative to prescription medication in relieving a variety of chronic medical conditions and illnesses.

About Stoic Advisory Inc.

Stoic Advisory Inc. is an independent Toronto-based consulting firm focused on providing corporate finance advisory services to companies within the global Cannabis industry. For more information, please visit stoicadvisory.com.

Follow WeedMD On:

Facebook: https://www.facebook.com/weedmd/

LinkedIn: https://www.linkedin.com/company-beta/5020743/

Twitter: https://twitter.com/WeedMD

Instagram: https://www.instagram.com/weedmd/

Forward-Looking Information

This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Company's common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

For further information, please contact: WeedMD Inc. Keith Merker, Chief Financial Officer Tel: 519-765-2440 Ext. 222 Email: investor@weedmd.com To learn more, visit us at www.weedmd.com For Media Inquiries: Marianella delaBarrera Margin Communications & Public Relations Tel: 416-897-6644 Email: marianella@marginpr.com